Legal Cannabis Industry Growth in 2016

Wednesday, November 16, 2016 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, November 16, 2016 /PRNewswire/ -- - Americans are more open minded about

cannabis use than ever before. This election year, at least several states voted to legalize cannabis in some form, with California, Massachusetts, Main and Nevada
voted to legalize recreational cannabis for adults, while Arkansas, Florida, and North Dakota legalized medical cannabis. California is the largest cannabis market in the United States, and legalization of recreational marijuana in the state is crucial for the growth of the market. Bang Holdings Corporation (OTC: BXNG), Cara Therapeutics Inc. (NASDAQ: CARA), American Cannabis Company Inc. (OTC: AMMJ), Medicine Man Technologies, Inc. (OTC: MDCL), Cannabis Sativa Inc. (OTC: CBDS)

The legal marijuana industry could generate roughly $22 billion in annual sales across the United States by 2020. This is according to a research report which was jointly released by New Frontier and ArcView. California's legal marijuana market could reach $7.6 billion in annual sales by 2020 alone.

Bang Holdings Corporation (OTCQB: BXNG), through its subsidiary Bang Digital Media, is company that provides brand management, digital content and influencer-based marketing to the cannabis industry. Bang Holdings directly promotes companies in the legal cannabis industry to more than a million followers. The goal is to connect legal cannabis businesses with potential customers.  

Bang Holdings Corporation announced this week it, "believes that laws legalizing recreational cannabis use in California, Massachusetts, Maine and Nevada, along with medical marijuana initiatives passed in Montana, Florida, Arkansas, and North Dakota are game changers for their business, and that of their clients. "The legalization of recreational and medical cannabis in already tourist-friendly states like California and Nevada unlocks massive potential for industry growth," said Bang Holdings CEO, Steve Berke. "California alone represents the sixth biggest economy - not just in the United States - but in the world. We believe that the business opportunities are vast."

"Even with the majority of Americans now saying they support cannabis legalization, social media platforms like Facebook and Twitter and advertising providers such as Google still have a ban on cannabis-related advertising," Berke said, adding that "Bang has honed the perfect mix of technical prowess and creative aptitude necessary to generate successful marketing campaigns for our brands and clients. We're immensely excited about the growth potential these new markets will provide," Berke said. "Next year may prove to be a banner year for advertising and marketing in the cannabis industry, and we are looking forward to monetizing our beta platform in 2017."

Biotechnology Company, Cara Therapeutics Inc. (NASDAQ: CARA), is pleased to be actively enrolling late stage studies with both IV and oral formulations of CR845 for three significant unmet medical indications. In September 2016, Cara initiated the enrollment of a Phase 2b trial of Oral CR845 in roughly 330 patients for the treatment of pain associated with osteoarthritis and presented positive data at PAINWeek from the Phase 2a study of Oral CR845 in OA. In October, company initiated Phase 1 study with Oral CR845 in hemodialysis patients.

American Cannabis Company Inc. (OTCQB: AMMJ) announced it has signed a client in Pennsylvania that will be applying for the state's medical marijuana program in the near future.  The company anticipates to leverage this contract to secure additional profits through long-term consulting agreements, sales of ancillary products and services to aid cultivation operations. "As the sixth most populated state in the country, Pennsylvania is a major market in the growing medical cannabis framework. Our new client operates with the business acumen and a track record of success from within other sectors, and this experience will be key for them in the effort to realize their goal of operating within Pennsylvania's new medical marijuana program," mentioned President and CEO of American Cannabis Company, Corey Hollister.

Medicine Man Technologies, Inc. (OTCQB: MDCL). The company implemented a risk averse growing environment, applying high-tech indoor cannabis cultivation equipment and works in medical and adult use dispensaries. Medicine Man Technologies assisted Illinois and Nevada licensees to organize these practices after acquiring cultivation and dispensary operational licenses. Currently, the company has reinforced competitive application filings in Maryland and Hawaii and has pre-licensure clients in Texas, California, Florida, Ohio, Arkansas, and Oklahoma and has engaged potential clients in Alaska, Delaware, Utah, Michigan, Nebraska, Puerto Rico, and abroad.

Cannabis Sativa Inc. (OTCQB: CBDS) cultivates and markets natural cannabis products. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. The Company is developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals Incorporated. Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA, Face Garden, Body Garden and Lip Garden.

For the Latest Buzz in Financial News SIGN UP! Visit:

Subscribe Now! Watch Weekly Video Reports

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. has been compensated a total of six thousand dollars for financial news dissemination and pr services by a non-affiliated third party for bang holdings corp. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information: Media Contact: , +1-877-601-1879


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store